News

In an interview with Fortune on July 6, Colin Murdoch, Isomorphic Labs’ president and Google DeepMind’s chief business ...
Google Deepmind’s offshoot Isomorphic Labs is about to be a milestone: The first AI developed medication should go into the ...
A secretive, Google-backed lab is using artificial intelligence to invent new medicines for humanity's worst illnesses. But ...
Alphabet’s Isomorphic Labs, spun out of DeepMind, is preparing to start human trials of AI-designed drugs after raising $600 ...
One day we hope to be able to say — well, here’s a disease, and then click a button and out pops the design for a drug to ...
Isomorphic Labs is preparing to test AI-designed drugs in humans, marking a new phase in drug development with artificial ...
Google DeepMind's moonshot, Isomorphic Labs, is gearing up to launch its first ever human trial of AI-designed drugs. The ...
Isomorphic Labs, a subsidiary of Alphabet Inc., is close to human trials for its AI-designed medicines. Other companies are ...
Google DeepMind's Isomorphic Labs is preparing for human trials of AI-designed drugs, marking a significant advancement in ...
Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...
Google DeepMind's spinoff Isomorphic Labs is set to begin human trials of a drug desinged completely by Artificial ...
Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology drugs. In an interview with Fortune, Isomorphic Labs president Colin ...